Disclosures for "Samelisant (SUVN-G3031): Positive Results from Phase-2 Proof-of-concept, Double-blind, Placebo-controlled Study in Patients with Narcolepsy and an Update on Further Clinical Development"
-
Dr. Nirogi has nothing to disclose.
-
Author has nothing to disclose
-
Satish Jetta has received intellectual property interests from a discovery or technology relating to health care.
-
Vinod Goyal has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Palacharla has stock in Suven Life Sciences Limited. Mr. Palacharla has received intellectual property interests from a discovery or technology relating to health care.
-
Vijay Benade has nothing to disclose.
-
Anil Shinde has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Abraham has nothing to disclose.
-
Mr. Pandey has nothing to disclose.
-
Mr. S has nothing to disclose.
-
Mr. Mohammed has nothing to disclose.
-
Pradeep Jayarajan has stock in Suven Life Sciences. Pradeep Jayarajan has received intellectual property interests from a discovery or technology relating to health care.
-
Venkat Jasti has stock in Suven Life Sciences Ltd. Venkat Jasti has received intellectual property interests from a discovery or technology relating to health care.